FDA to discuss food safety communications
This article was originally published in The Tan Sheet
Executive SummaryFDA schedules a Risk Communication Advisory Committee meeting Aug. 13-14 in Washington to discuss "external research on, and internal assessment of, communications about food safety problems." A July 21 Federal Register notice says the meeting will address consumer knowledge of recalls and the agency's communication effectiveness. The committee then will advise FDA how to communicate more effectively
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.